Redhawk Wealth Advisors Inc. Purchases New Stake in Levi Strauss & Co. $LEVI

Redhawk Wealth Advisors Inc. acquired a new position in Levi Strauss & Co. (NYSE:LEVI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 32,773 shares of the blue-jean maker’s stock, valued at approximately $764,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Levi Strauss & Co. by 140.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,425 shares of the blue-jean maker’s stock valued at $26,000 after purchasing an additional 833 shares during the last quarter. Hara Capital LLC raised its stake in shares of Levi Strauss & Co. by 8,080.0% during the second quarter. Hara Capital LLC now owns 2,045 shares of the blue-jean maker’s stock worth $38,000 after buying an additional 2,020 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Levi Strauss & Co. by 133.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,286 shares of the blue-jean maker’s stock valued at $51,000 after buying an additional 1,879 shares during the period. First Command Advisory Services Inc. bought a new position in Levi Strauss & Co. in the second quarter valued at approximately $71,000. Finally, Headlands Technologies LLC boosted its stake in Levi Strauss & Co. by 17,721.6% in the second quarter. Headlands Technologies LLC now owns 6,594 shares of the blue-jean maker’s stock valued at $122,000 after acquiring an additional 6,557 shares during the last quarter. 69.14% of the stock is owned by institutional investors.

Levi Strauss & Co. Stock Down 1.1%

Shares of Levi Strauss & Co. stock opened at $21.67 on Friday. Levi Strauss & Co. has a 1 year low of $12.17 and a 1 year high of $24.82. The business has a 50-day moving average of $21.22 and a two-hundred day moving average of $20.89. The company has a market capitalization of $8.47 billion, a P/E ratio of 14.26, a price-to-earnings-growth ratio of 1.47 and a beta of 1.34. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.52 and a quick ratio of 0.87.

Levi Strauss & Co. (NYSE:LEVI) last released its quarterly earnings data on Thursday, October 9th. The blue-jean maker reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.03. Levi Strauss & Co. had a return on equity of 27.92% and a net margin of 9.48%.The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same quarter in the previous year, the business posted $0.33 EPS. Levi Strauss & Co.’s revenue for the quarter was up 7.0% on a year-over-year basis. Levi Strauss & Co. has set its FY 2025 guidance at 1.270-1.320 EPS. As a group, equities analysts predict that Levi Strauss & Co. will post 1.27 EPS for the current year.

Levi Strauss & Co. Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 4th. Shareholders of record on Monday, October 20th were paid a $0.14 dividend. The ex-dividend date of this dividend was Monday, October 20th. This represents a $0.56 dividend on an annualized basis and a yield of 2.6%. Levi Strauss & Co.’s payout ratio is presently 36.84%.

Analyst Ratings Changes

LEVI has been the topic of a number of analyst reports. Telsey Advisory Group reissued an “outperform” rating and issued a $27.00 price target on shares of Levi Strauss & Co. in a research note on Friday, October 10th. JPMorgan Chase & Co. increased their target price on Levi Strauss & Co. from $23.00 to $33.00 and gave the company an “overweight” rating in a research note on Friday, October 10th. UBS Group raised their target price on Levi Strauss & Co. from $28.00 to $32.00 and gave the stock a “buy” rating in a report on Friday, October 10th. Morgan Stanley upped their price target on Levi Strauss & Co. from $19.00 to $20.00 and gave the company an “equal weight” rating in a research note on Friday, October 10th. Finally, Needham & Company LLC began coverage on shares of Levi Strauss & Co. in a research note on Thursday, September 25th. They set a “buy” rating and a $28.00 price objective on the stock. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.42.

Insider Activity at Levi Strauss & Co.

In other news, major shareholder E. Haas Jr. Family Fund Peter sold 150,000 shares of the stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $24.19, for a total transaction of $3,628,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Margaret E. Haas sold 50,000 shares of the firm’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $24.14, for a total transaction of $1,207,000.00. The disclosure for this sale is available in the SEC filing. 1.25% of the stock is owned by corporate insiders.

About Levi Strauss & Co.

Levi Strauss & Co is a global apparel company best known for its denim jeans and casual wear. Founded in 1853 in San Francisco by Bavarian immigrant Levi Strauss, the company pioneered the modern blue jean with the introduction of rivet-reinforced work pants. Over its more than 160-year history, Levi Strauss has evolved into a lifestyle brand, offering a broad portfolio that includes denim for men, women and children, as well as tops, outerwear, footwear and accessories.

The company’s flagship label, Levi’s®, is recognized worldwide for its iconic styles such as the 501® Original Fit Jeans, while additional brands, including Dockers®, Target core metric, and Denizen® by Levi’s, cater to diverse price points and consumer segments.